Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 253

1.

Understanding the Risk of Treatment Failure After Discontinuation of Long-Term Antipsychotic Treatment.

Czobor P, Volavka J.

Am J Psychiatry. 2018 Sep 1;175(9):908-909. doi: 10.1176/appi.ajp.2018.18050610. No abstract available.

PMID:
30173547
2.

Very long-term outcome of schizophrenia.

Volavka J, Vevera J.

Int J Clin Pract. 2018 Jul;72(7):e13094. doi: 10.1111/ijcp.13094. Epub 2018 Apr 24. Review.

PMID:
29691957
3.

Measurement of agitation and aggression in adult and aged neuropsychiatric patients: review of definitions and frequently used measurement scales.

Volicer L, Citrome L, Volavka J.

CNS Spectr. 2017 Oct;22(5):407-414. doi: 10.1017/S1092852917000050. Epub 2017 Feb 9.

PMID:
28179043
4.

Triggering Violence in Psychosis.

Volavka J.

JAMA Psychiatry. 2016 Aug 1;73(8):769-70. doi: 10.1001/jamapsychiatry.2016.1348. No abstract available.

PMID:
27409516
5.

Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies.

Volavka J, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Czobor P.

Eur Psychiatry. 2016 Jan;31:13-9. doi: 10.1016/j.eurpsy.2015.10.003. Epub 2015 Dec 4.

6.

Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.

Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1158-66. doi: 10.1016/j.euroneuro.2015.04.003. Epub 2015 Apr 30.

7.

Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study - ADDENDUM.

Volavka J, Czobor P, Citrome L, Van Dorn RA.

CNS Spectr. 2014 Oct;19(5):466. doi: 10.1017/S1092852914000364. Epub 2014 Jul 14. No abstract available.

PMID:
25017569
8.

The psychopharmacology of violence: making sensible decisions.

Citrome L, Volavka J.

CNS Spectr. 2014 Oct;19(5):411-8. doi: 10.1017/S1092852914000054. Epub 2014 Feb 26. Review.

PMID:
24571828
9.

Why is ITAREPS successful?

Volavka J.

Schizophr Res. 2014 Feb;152(2-3):530. doi: 10.1016/j.schres.2013.12.010. Epub 2014 Jan 11. No abstract available.

PMID:
24418123
10.

Review: 15 antipsychotic drugs are more effective than placebo for the treatment of schizophrenia, but vary in their tolerability.

Citrome L, Volavka J.

Evid Based Ment Health. 2014 Feb;17(1):9. doi: 10.1136/eb-2013-101612. Epub 2013 Dec 16. No abstract available.

PMID:
24344173
11.

Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.

Volavka J, Czobor P, Citrome L, Van Dorn RA.

CNS Spectr. 2014 Oct;19(5):374-81. doi: 10.1017/S1092852913000849. Epub 2013 Nov 28. Erratum in: CNS Spectr. 2014 Oct;19(5):466.

12.

Comorbid personality disorders and violent behavior in psychotic patients.

Volavka J.

Psychiatr Q. 2014 Mar;85(1):65-78. doi: 10.1007/s11126-013-9273-3. Review.

PMID:
24057452
13.

Violence in schizophrenia and bipolar disorder.

Volavka J.

Psychiatr Danub. 2013 Mar;25(1):24-33. Review.

14.

Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial.

Czobor P, Volavka J, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW; EUFEST Study Group.

J Clin Psychopharmacol. 2013 Apr;33(2):258-61. doi: 10.1097/JCP.0b013e3182856886. No abstract available.

PMID:
23422388
15.

[How to read critically a scientific paper].

Mohr P, Höschl C, Volavka J.

Cas Lek Cesk. 2012;151(10):476-9. Czech.

PMID:
23256633
16.

A meta-analysis of the Val158Met COMT polymorphism and violent behavior in schizophrenia.

Singh JP, Volavka J, Czobor P, Van Dorn RA.

PLoS One. 2012;7(8):e43423. doi: 10.1371/journal.pone.0043423. Epub 2012 Aug 14.

17.

Teaching critical appraisal of articles on psychopharmacology.

Mohr P, Höschl C, Volavka J.

Acad Psychiatry. 2012 Mar 1;36(2):114-7. doi: 10.1176/appi.ap.10070100.

PMID:
22532200
18.

Clozapine is gold standard, but questions remain.

Volavka J.

Int J Neuropsychopharmacol. 2012 Oct;15(9):1201-4. doi: 10.1017/S1461145712000284. Epub 2012 Apr 4. No abstract available.

PMID:
22475059
19.

Violent crime, epilepsy, and traumatic brain injury.

Volavka J.

PLoS Med. 2011 Dec;8(12):e1001148. doi: 10.1371/journal.pmed.1001148. Epub 2011 Dec 27. No abstract available.

20.

Pharmacological management of acute and persistent aggression in forensic psychiatry settings.

Citrome L, Volavka J.

CNS Drugs. 2011 Dec 1;25(12):1009-21. doi: 10.2165/11596930-000000000-00000. Review.

PMID:
22133324

Supplemental Content

Loading ...
Support Center